Intrinsic value of Chemours - CC

Previous Close

$51.08

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$51.08

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of CC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -5.54
  13.30
  12.47
  11.72
  11.05
  10.45
  9.90
  9.41
  8.97
  8.57
  8.22
  7.89
  7.60
  7.34
  7.11
  6.90
  6.71
  6.54
  6.38
  6.25
  6.12
  6.01
  5.91
  5.82
  5.74
  5.66
  5.60
  5.54
  5.48
  5.43
  5.39
Revenue, $m
  5,400
  6,118
  6,881
  7,688
  8,537
  9,429
  10,363
  11,338
  12,355
  13,414
  14,516
  15,662
  16,853
  18,091
  19,377
  20,714
  22,104
  23,549
  25,052
  26,617
  28,246
  29,943
  31,713
  33,557
  35,482
  37,491
  39,589
  41,781
  44,071
  46,466
  48,971
Variable operating expenses, $m
 
  6,257
  7,035
  7,858
  8,725
  9,635
  10,587
  11,582
  12,619
  13,700
  14,824
  15,978
  17,193
  18,456
  19,768
  21,132
  22,549
  24,024
  25,557
  27,154
  28,816
  30,547
  32,352
  34,234
  36,198
  38,247
  40,387
  42,623
  44,960
  47,404
  49,959
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  5,474
  6,257
  7,035
  7,858
  8,725
  9,635
  10,587
  11,582
  12,619
  13,700
  14,824
  15,978
  17,193
  18,456
  19,768
  21,132
  22,549
  24,024
  25,557
  27,154
  28,816
  30,547
  32,352
  34,234
  36,198
  38,247
  40,387
  42,623
  44,960
  47,404
  49,959
Operating income, $m
  -74
  -139
  -154
  -170
  -187
  -205
  -224
  -244
  -264
  -286
  -308
  -316
  -340
  -365
  -391
  -418
  -446
  -475
  -505
  -537
  -570
  -604
  -640
  -677
  -716
  -756
  -798
  -843
  -889
  -937
  -988
EBITDA, $m
  210
  182
  205
  229
  254
  280
  308
  337
  367
  399
  432
  466
  501
  538
  576
  616
  657
  700
  745
  792
  840
  891
  943
  998
  1,055
  1,115
  1,178
  1,243
  1,311
  1,382
  1,457
Interest expense (income), $m
  208
  194
  156
  192
  231
  271
  313
  357
  403
  451
  501
  553
  608
  664
  722
  783
  846
  912
  980
  1,052
  1,126
  1,203
  1,283
  1,366
  1,454
  1,545
  1,640
  1,739
  1,842
  1,951
  2,064
Earnings before tax, $m
  -11
  -333
  -310
  -363
  -418
  -476
  -537
  -601
  -668
  -737
  -809
  -869
  -947
  -1,029
  -1,113
  -1,201
  -1,292
  -1,387
  -1,486
  -1,588
  -1,695
  -1,806
  -1,922
  -2,043
  -2,169
  -2,301
  -2,438
  -2,581
  -2,731
  -2,888
  -3,052
Tax expense, $m
  -18
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  7
  -333
  -310
  -363
  -418
  -476
  -537
  -601
  -668
  -737
  -809
  -869
  -947
  -1,029
  -1,113
  -1,201
  -1,292
  -1,387
  -1,486
  -1,588
  -1,695
  -1,806
  -1,922
  -2,043
  -2,169
  -2,301
  -2,438
  -2,581
  -2,731
  -2,888
  -3,052

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  902
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,060
  5,844
  6,572
  7,343
  8,154
  9,006
  9,898
  10,829
  11,800
  12,812
  13,865
  14,959
  16,097
  17,279
  18,507
  19,784
  21,111
  22,492
  23,928
  25,422
  26,978
  28,599
  30,289
  32,051
  33,889
  35,808
  37,812
  39,905
  42,093
  44,381
  46,773
Adjusted assets (=assets-cash), $m
  5,158
  5,844
  6,572
  7,343
  8,154
  9,006
  9,898
  10,829
  11,800
  12,812
  13,865
  14,959
  16,097
  17,279
  18,507
  19,784
  21,111
  22,492
  23,928
  25,422
  26,978
  28,599
  30,289
  32,051
  33,889
  35,808
  37,812
  39,905
  42,093
  44,381
  46,773
Revenue / Adjusted assets
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
Average production assets, $m
  2,994
  3,389
  3,812
  4,259
  4,730
  5,224
  5,741
  6,281
  6,845
  7,431
  8,042
  8,677
  9,337
  10,022
  10,735
  11,475
  12,245
  13,046
  13,879
  14,746
  15,648
  16,589
  17,569
  18,591
  19,657
  20,770
  21,932
  23,147
  24,416
  25,742
  27,130
Working capital, $m
  782
  -116
  -131
  -146
  -162
  -179
  -197
  -215
  -235
  -255
  -276
  -298
  -320
  -344
  -368
  -394
  -420
  -447
  -476
  -506
  -537
  -569
  -603
  -638
  -674
  -712
  -752
  -794
  -837
  -883
  -930
Total debt, $m
  3,544
  2,843
  3,499
  4,192
  4,923
  5,689
  6,492
  7,330
  8,204
  9,115
  10,062
  11,047
  12,071
  13,135
  14,241
  15,390
  16,584
  17,826
  19,119
  20,464
  21,864
  23,323
  24,844
  26,430
  28,084
  29,811
  31,615
  33,499
  35,468
  37,527
  39,680
Total liabilities, $m
  5,960
  5,259
  5,915
  6,608
  7,339
  8,105
  8,908
  9,746
  10,620
  11,531
  12,478
  13,463
  14,487
  15,551
  16,657
  17,806
  19,000
  20,242
  21,535
  22,880
  24,280
  25,739
  27,260
  28,846
  30,500
  32,227
  34,031
  35,915
  37,884
  39,943
  42,096
Total equity, $m
  100
  584
  657
  734
  815
  901
  990
  1,083
  1,180
  1,281
  1,386
  1,496
  1,610
  1,728
  1,851
  1,978
  2,111
  2,249
  2,393
  2,542
  2,698
  2,860
  3,029
  3,205
  3,389
  3,581
  3,781
  3,991
  4,209
  4,438
  4,677
Total liabilities and equity, $m
  6,060
  5,843
  6,572
  7,342
  8,154
  9,006
  9,898
  10,829
  11,800
  12,812
  13,864
  14,959
  16,097
  17,279
  18,508
  19,784
  21,111
  22,491
  23,928
  25,422
  26,978
  28,599
  30,289
  32,051
  33,889
  35,808
  37,812
  39,906
  42,093
  44,381
  46,773
Debt-to-equity ratio
  35.440
  4.870
  5.320
  5.710
  6.040
  6.320
  6.560
  6.770
  6.950
  7.110
  7.260
  7.380
  7.500
  7.600
  7.690
  7.780
  7.860
  7.930
  7.990
  8.050
  8.100
  8.160
  8.200
  8.250
  8.290
  8.330
  8.360
  8.390
  8.430
  8.460
  8.480
Adjusted equity ratio
  -0.155
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  7
  -333
  -310
  -363
  -418
  -476
  -537
  -601
  -668
  -737
  -809
  -869
  -947
  -1,029
  -1,113
  -1,201
  -1,292
  -1,387
  -1,486
  -1,588
  -1,695
  -1,806
  -1,922
  -2,043
  -2,169
  -2,301
  -2,438
  -2,581
  -2,731
  -2,888
  -3,052
Depreciation, amort., depletion, $m
  284
  321
  359
  399
  441
  486
  533
  581
  632
  685
  740
  782
  841
  903
  967
  1,034
  1,103
  1,175
  1,250
  1,328
  1,410
  1,494
  1,583
  1,675
  1,771
  1,871
  1,976
  2,085
  2,200
  2,319
  2,444
Funds from operations, $m
  1,078
  -12
  48
  36
  23
  10
  -5
  -20
  -36
  -52
  -70
  -88
  -106
  -126
  -146
  -167
  -189
  -212
  -235
  -260
  -285
  -312
  -340
  -368
  -398
  -430
  -462
  -496
  -532
  -569
  -607
Change in working capital, $m
  484
  -14
  -14
  -15
  -16
  -17
  -18
  -19
  -19
  -20
  -21
  -22
  -23
  -24
  -24
  -25
  -26
  -27
  -29
  -30
  -31
  -32
  -34
  -35
  -37
  -38
  -40
  -42
  -44
  -46
  -48
Cash from operations, $m
  594
  2
  63
  52
  39
  27
  13
  -1
  -16
  -32
  -49
  -66
  -84
  -102
  -122
  -142
  -163
  -184
  -207
  -230
  -254
  -280
  -306
  -333
  -362
  -391
  -422
  -454
  -488
  -523
  -560
Maintenance CAPEX, $m
  0
  -270
  -305
  -343
  -384
  -426
  -471
  -517
  -566
  -617
  -669
  -725
  -782
  -841
  -903
  -967
  -1,034
  -1,103
  -1,175
  -1,250
  -1,328
  -1,410
  -1,494
  -1,583
  -1,675
  -1,771
  -1,871
  -1,976
  -2,085
  -2,200
  -2,319
New CAPEX, $m
  -338
  -395
  -423
  -447
  -471
  -494
  -517
  -540
  -563
  -587
  -611
  -635
  -660
  -686
  -713
  -741
  -770
  -801
  -833
  -867
  -903
  -940
  -980
  -1,022
  -1,066
  -1,113
  -1,162
  -1,214
  -1,269
  -1,327
  -1,388
Cash from investing activities, $m
  357
  -665
  -728
  -790
  -855
  -920
  -988
  -1,057
  -1,129
  -1,204
  -1,280
  -1,360
  -1,442
  -1,527
  -1,616
  -1,708
  -1,804
  -1,904
  -2,008
  -2,117
  -2,231
  -2,350
  -2,474
  -2,605
  -2,741
  -2,884
  -3,033
  -3,190
  -3,354
  -3,527
  -3,707
Free cash flow, $m
  951
  -664
  -665
  -739
  -815
  -893
  -975
  -1,059
  -1,146
  -1,236
  -1,329
  -1,425
  -1,525
  -1,629
  -1,737
  -1,849
  -1,966
  -2,088
  -2,215
  -2,347
  -2,485
  -2,630
  -2,780
  -2,938
  -3,103
  -3,275
  -3,456
  -3,645
  -3,842
  -4,050
  -4,267
Issuance/(repayment) of debt, $m
  -381
  -686
  656
  693
  730
  767
  803
  838
  874
  910
  947
  985
  1,024
  1,064
  1,106
  1,149
  1,195
  1,242
  1,292
  1,345
  1,401
  1,459
  1,521
  1,586
  1,654
  1,727
  1,803
  1,884
  1,969
  2,059
  2,153
Issuance/(repurchase) of shares, $m
  11
  1,704
  383
  440
  499
  561
  626
  694
  765
  838
  915
  979
  1,061
  1,147
  1,236
  1,329
  1,425
  1,525
  1,629
  1,738
  1,851
  1,969
  2,091
  2,219
  2,353
  2,493
  2,638
  2,791
  2,950
  3,117
  3,291
Cash from financing (excl. dividends), $m  
  -374
  1,018
  1,039
  1,133
  1,229
  1,328
  1,429
  1,532
  1,639
  1,748
  1,862
  1,964
  2,085
  2,211
  2,342
  2,478
  2,620
  2,767
  2,921
  3,083
  3,252
  3,428
  3,612
  3,805
  4,007
  4,220
  4,441
  4,675
  4,919
  5,176
  5,444
Total cash flow (excl. dividends), $m
  558
  355
  374
  394
  415
  434
  454
  474
  493
  513
  533
  539
  560
  582
  605
  628
  653
  679
  707
  735
  766
  798
  832
  867
  905
  944
  986
  1,030
  1,077
  1,126
  1,177
Retained Cash Flow (-), $m
  26
  -1,704
  -383
  -440
  -499
  -561
  -626
  -694
  -765
  -838
  -915
  -979
  -1,061
  -1,147
  -1,236
  -1,329
  -1,425
  -1,525
  -1,629
  -1,738
  -1,851
  -1,969
  -2,091
  -2,219
  -2,353
  -2,493
  -2,638
  -2,791
  -2,950
  -3,117
  -3,291
Prev. year cash balance distribution, $m
 
  887
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  -462
  -9
  -45
  -85
  -127
  -172
  -220
  -271
  -325
  -381
  -440
  -501
  -565
  -631
  -700
  -772
  -846
  -923
  -1,002
  -1,085
  -1,171
  -1,260
  -1,352
  -1,448
  -1,548
  -1,652
  -1,761
  -1,873
  -1,991
  -2,113
Discount rate, %
 
  11.80
  12.39
  13.01
  13.66
  14.34
  15.06
  15.81
  16.60
  17.43
  18.31
  19.22
  20.18
  21.19
  22.25
  23.36
  24.53
  25.76
  27.05
  28.40
  29.82
  31.31
  32.87
  34.52
  36.24
  38.06
  39.96
  41.96
  44.05
  46.26
  48.57
PV of cash for distribution, $m
 
  -414
  -7
  -31
  -51
  -65
  -74
  -79
  -79
  -77
  -71
  -64
  -55
  -46
  -38
  -30
  -23
  -17
  -12
  -9
  -6
  -4
  -2
  -1
  -1
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  50.0
  46.9
  44.0
  41.2
  38.5
  36.0
  33.7
  31.4
  29.4
  27.4
  25.6
  23.9
  22.3
  20.8
  19.4
  18.1
  16.9
  15.8
  14.7
  13.7
  12.8
  11.9
  11.1
  10.3
  9.6
  9.0
  8.3
  7.8
  7.2
  6.7

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

FINANCIAL RATIOS  of  Chemours (CC)

Valuation Ratios
P/E Ratio 1332.5
Price to Sales 1.7
Price to Book 93.3
Price to Tangible Book
Price to Cash Flow 15.7
Price to Free Cash Flow 36.4
Growth Rates
Sales Growth Rate -5.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -34.9%
Cap. Spend. - 3 Yr. Gr. Rate -5.1%
Financial Strength
Quick Ratio 60
Current Ratio 0
LT Debt to Equity 3529%
Total Debt to Equity 3544%
Interest Coverage 1
Management Effectiveness
Return On Assets -2%
Ret/ On Assets - 3 Yr. Avg. 1.4%
Return On Total Capital 0.2%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 6.2%
Return On Equity - 3 Yr. Avg. 4.4%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 20.6%
Gross Margin - 3 Yr. Avg. 19.5%
EBITDA Margin 8.9%
EBITDA Margin - 3 Yr. Avg. 8.2%
Operating Margin -1.4%
Oper. Margin - 3 Yr. Avg. 1.4%
Pre-Tax Margin -0.2%
Pre-Tax Margin - 3 Yr. Avg. 1.7%
Net Profit Margin 0.1%
Net Profit Margin - 3 Yr. Avg. 1.6%
Effective Tax Rate 163.6%
Eff/ Tax Rate - 3 Yr. Avg. 81%
Payout Ratio 314.3%

CC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CC stock intrinsic value calculation we used $5400 million for the last fiscal year's total revenue generated by Chemours. The default revenue input number comes from 2016 income statement of Chemours. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CC stock valuation model: a) initial revenue growth rate of 13.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 11.8%, whose default value for CC is calculated based on our internal credit rating of Chemours, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Chemours.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CC stock the variable cost ratio is equal to 102.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.5% for Chemours.

Corporate tax rate of 27% is the nominal tax rate for Chemours. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CC are equal to 55.4%.

Life of production assets of 11.1 years is the average useful life of capital assets used in Chemours operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CC is equal to -1.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $100 million for Chemours - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 187.375 million for Chemours is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Chemours at the current share price and the inputted number of shares is $9.6 billion.

RELATED COMPANIES Price Int.Val. Rating
MMM 3M 237.02 160.70  sell
HUN Huntsman 33.64 31.79  hold
KRO Kronos Worldwi 24.13 0.83  str.sell
OXY Occidental Pet 68.32 7.02  str.sell
HON Honeywell Inte 155.12 134.30  hold

COMPANY NEWS

▶ 3 Lousy Stocks I'd Avoid   [Feb-23-18 08:02AM  Motley Fool]
▶ Chemours Co. to Host Earnings Call   [06:20AM  ACCESSWIRE]
▶ Chemours beats 4Q profit forecasts   [Feb-14-18 05:55PM  Associated Press]
▶ Chemours shares rise after earnings beat   [04:48PM  MarketWatch]
▶ A Preview Of Chemours Q4 Earnings   [10:43AM  Benzinga]
▶ How Financially Strong Is The Chemours Company (NYSE:CC)?   [Dec-27-17 03:15PM  Simply Wall St.]
▶ Chemours to Increase Fluoropolymer Prices   [Dec-26-17 08:28AM  Market Realist]
▶ Chemours Announces Fluoropolymer Price Increase   [Dec-21-17 08:30AM  PR Newswire]
▶ 3 Embarrassingly Low Dividend Stocks   [Dec-06-17 08:16AM  Motley Fool]
▶ 3 Stocks Set to Drop   [Dec-04-17 11:42AM  Motley Fool]
▶ Cemours first ever investor day   [04:45PM  CNBC Videos]
▶ Chemours Company: Bulls Need a Reality Check   [Nov-30-17 09:19AM  Motley Fool]
▶ 3 Stocks To Buy On The Dip Right Now   [Nov-15-17 05:53PM  Zacks]
▶ Chemours to Pay a 4Q17 Dividend   [Nov-13-17 11:32AM  Market Realist]
▶ Chemours Announces Fourth Quarter Dividend   [Nov-07-17 04:01PM  PR Newswire]
▶ Chemours posts 3Q profit   [05:38AM  Associated Press]
▶ How Axalta went from loser to takeover target   [Nov-03-17 06:53PM  CNBC Videos]
▶ [$$] How a DuPont Carve-Out Made a Comeback   [12:39PM  The Wall Street Journal]
▶ Chemours Co. to Host Earnings Call   [06:45AM  ACCESSWIRE]
▶ Chemours shares down 3% after third-quarter earnings   [Nov-02-17 05:39PM  MarketWatch]
▶ At $56.97, Is The Chemours Company (CC) A Sell?   [08:52AM  Simply Wall St.]
▶ Cape Fear Public Utility Authority files GenX suit against DuPont, Chemours   [Oct-19-17 12:00PM  American City Business Journals]
▶ ETFs with exposure to The Chemours Co. : October 17, 2017   [Oct-17-17 09:37AM  Capital Cube]
▶ 3 Stocks I Never Plan to Buy   [08:09AM  Motley Fool]
▶ Opteon 1100 Wins 2017 Polyurethane Innovation Award   [Oct-04-17 05:20PM  PR Newswire]
▶ ETFs with exposure to The Chemours Co. : October 3, 2017   [Oct-03-17 11:01AM  Capital Cube]
▶ Opteon XL40 Honored at the RAC Cooling Industry Awards   [Sep-27-17 09:06PM  PR Newswire]
▶ Tronox Will Raise $450 Million through Senior Notes   [Sep-18-17 03:06PM  Market Realist]
▶ Chemours Has Continued Its Upward Momentum in 2017   [Sep-14-17 07:40AM  Market Realist]
▶ Chemours: Analysts Recommendations and More   [Sep-13-17 01:35PM  Market Realist]
▶ Why Is Chemours Dividend Yield Low?   [12:06PM  Market Realist]
▶ Chemours: Analyzing Its 3Q17 Dividend   [10:22AM  Market Realist]
▶ 3 Stocks With Facebook-Like Return Potential   [Sep-12-17 09:45AM  Motley Fool]
▶ Top Ranked Growth Stocks to Buy for August 30th   [Aug-30-17 08:52AM  Zacks]
Financial statements of CC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.